Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A pilot program of HIV pre-exposure prophylaxis in Thai youth.
Rungmaitree S, Werarak P, Pumpradit W, Phongsamart W, Lapphra K, Wittawatmongkol O, Durier Y, Maleesatharn A, Kuttiparambil B, Cressey TR, Hoffman RM, Chokephaibulkit K. Rungmaitree S, et al. Among authors: cressey tr. PLoS One. 2024 Feb 22;19(2):e0298914. doi: 10.1371/journal.pone.0298914. eCollection 2024. PLoS One. 2024. PMID: 38386680 Free PMC article.
A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand.
Vanprapar N, Cressey TR, Chokephaibulkit K, Muresan P, Plipat N, Sirisanthana V, Prasitsuebsai W, Hongsiriwan S, Chotpitayasunondh T, Eksaengsri A, Toye M, Smith ME, McIntosh K, Capparelli E, Yogev R; IMPAACT P1056 Team. Vanprapar N, et al. Among authors: cressey tr. Pediatr Infect Dis J. 2010 Oct;29(10):940-4. doi: 10.1097/INF.0b013e3181e2189d. Pediatr Infect Dis J. 2010. PMID: 20453709 Free PMC article. Clinical Trial.
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum.
Cressey TR, Stek A, Capparelli E, Bowonwatanuwong C, Prommas S, Sirivatanapa P, Yuthavisuthi P, Neungton C, Huo Y, Smith E, Best BM, Mirochnick M; IMPAACT P1026s Team. Cressey TR, et al. J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):245-52. doi: 10.1097/QAI.0b013e31823ff052. J Acquir Immune Defic Syndr. 2012. PMID: 22083071 Free PMC article. Clinical Trial.
Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation.
Prasitsuebsai W, Cressey TR, Capparelli E, Vanprapar N, Lapphra K, Chokephaibulkit K. Prasitsuebsai W, et al. Among authors: cressey tr. Pediatr Infect Dis J. 2012 Apr;31(4):389-91. doi: 10.1097/INF.0b013e3182401c41. Pediatr Infect Dis J. 2012. PMID: 22146740
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children.
Chokephaibulkit K, Cressey TR, Capparelli E, Sirisanthana V, Muresan P, Hongsiriwon S, Ngampiyaskul C, Limwongse C, Wittawatmongkol O, Aurpibul L, Kabat B, Toye M, Smith ME, Eksaengsri A, McIntosh K, Yogev R; IMPAACT P1069 Team. Chokephaibulkit K, et al. Among authors: cressey tr. Antivir Ther. 2011;16(8):1287-95. doi: 10.3851/IMP1931. Antivir Ther. 2011. PMID: 22155910 Free PMC article. Clinical Trial.
Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir.
Chokephaibulkit K, Nuntarukchaikul M, Phongsamart W, Wittawatmongkol O, Lapphra K, Vanprapar N, Cressey TR. Chokephaibulkit K, et al. Among authors: cressey tr. J Antimicrob Chemother. 2012 Dec;67(12):2927-31. doi: 10.1093/jac/dks332. Epub 2012 Aug 23. J Antimicrob Chemother. 2012. PMID: 22923483 Clinical Trial.
157 results